Thomas Haalck

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.

Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 26, 2025

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.

Journal: Journal for immunotherapy of cancer

Published: April 28, 2023

Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.

Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 19, 2023

Decision criteria and patient characteristics for patient-oriented treatment of field cancerization : Standardized algorithm for personalized treatment concepts

Decision criteria and patient characteristics for patient-oriented treatment of field cancerization : Standardized algorithm for personalized treatment concepts

Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete

Published: December 02, 2020

Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.

Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.

Journal: Advances in therapy

Published: April 30, 2020

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 04, 2019

Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.

Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.

Journal: PloS one

Published: September 12, 2017

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Journal: Medicine

Published: November 19, 2016

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker.

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker.

Journal: International journal of cancer

Published: August 09, 2016

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 28, 2015

The microenvironment in the human lung partly determines the site of the first metastasis.

The microenvironment in the human lung partly determines the site of the first metastasis.

Journal: Anticancer research

Published: July 02, 2014

Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.

Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.

Journal: Acta haematologica

Published: May 14, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026